Literature DB >> 8687109

Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers.

J Yokoyama1, K Shiga, H Sasano, M Suzuki, T Takasaka.   

Abstract

Abnormalities in the Retinoblastoma tumor suppressor gene (Rb) have been observed in a large number of human cancers. Loss of heterozygosity (LOH) is a common mode of allelic inactivation of Rb and other tumor suppressor genes. We investigated DNA from 45 primary human head and neck cancers to determine LOH at the Rb locus using a polymerase chain reaction-based restriction fragment length polymorphism assay. Of informative cases, we found LOH in 4 of 28 (14%) head and neck cancers. Of immunohistochemical staining of Rb protein, we found that in one of ten LOH negative cases the nuclei of fibroblasts were stained with anti-Rb antibody but there was no nuclear staining tumor cells. These results suggest that inactivation of Rb protein is involved in the carcinogenesis of head and neck cancer at all levels of the process of protein expression: DNA, mRNA and protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687109

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product.

Authors:  M L Gulley; J M Nicholls; B G Schneider; M B Amin; J Y Ro; J Geradts
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

2.  Retinoblastoma gene abnormalities in early laryngeal cancer.

Authors:  Mark Rafferty; Carol Walker; David Husband; Timothy Helliwell; John Fenton; Andrew Jones
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-03       Impact factor: 2.503

Review 3.  A genetic view of laryngeal cancer heterogeneity.

Authors:  María José de Miguel-Luken; Manuel Chaves-Conde; Amancio Carnero
Journal:  Cell Cycle       Date:  2016-03-03       Impact factor: 4.534

4.  DNA hypermethylation markers of poor outcome in laryngeal cancer.

Authors:  Josena K Stephen; Kang Mei Chen; Veena Shah; Shaleta Havard; Alissa Kapke; Mei Lu; Michael S Benninger; Maria J Worsham
Journal:  Clin Epigenetics       Date:  2010-09-01       Impact factor: 6.551

5.  Immunohistochemical Expression of Five Protein Combinations Revealed as Prognostic Markers in Asian Oral Cancer.

Authors:  Hui-Ching Wang; Chien-Jung Chiang; Ta-Chih Liu; Chun-Chieh Wu; Yi-Ting Chen; Jan-Gowth Chang; Grace S Shieh
Journal:  Front Genet       Date:  2021-04-15       Impact factor: 4.599

6.  Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer.

Authors:  M M Sasiadek; A Stembalska-Kozlowska; R Smigiel; D Ramsey; T Kayademir; N Blin
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

7.  The expression of retinoblastoma tumor suppressor protein in oral cancers and precancers: A clinicopathological study.

Authors:  Sunila Thomas; Anita Balan; Prabha Balaram
Journal:  Dent Res J (Isfahan)       Date:  2015 Jul-Aug
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.